Xiaoling Li

10.4k total citations · 3 hit papers
224 papers, 6.9k citations indexed

About

Xiaoling Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaoling Li has authored 224 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Molecular Biology, 47 papers in Pulmonary and Respiratory Medicine and 38 papers in Oncology. Recurrent topics in Xiaoling Li's work include Chromatin Remodeling and Cancer (17 papers), RNA modifications and cancer (16 papers) and Lung Cancer Treatments and Mutations (15 papers). Xiaoling Li is often cited by papers focused on Chromatin Remodeling and Cancer (17 papers), RNA modifications and cancer (16 papers) and Lung Cancer Treatments and Mutations (15 papers). Xiaoling Li collaborates with scholars based in China, United States and Netherlands. Xiaoling Li's co-authors include Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Can Guo, Bo Xiang, Yong Li, Ming Zhou, Yongzhen Mo, Fang Xiong and Lianxiang Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Xiaoling Li

214 papers receiving 6.8k citations

Hit Papers

Neoantigen vaccine: an emerging tumor immunotherapy 2019 2026 2021 2023 2019 2020 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neoantigen vaccine: an emerging tumor immunotherapy
    2019 524 citations Xiaoling Li, Guiyuan Li et al. profile →
  2. The role of microenvironment in tumor angiogenesis
    2020 514 citations Guiyuan Li, Xiaoling Li et al. profile →
  3. Single‐cell RNA sequencing in cancer research
    2021 234 citations Xiaoling Li, Guiyuan Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Li China 45 3.6k 1.8k 1.4k 1.3k 1.1k 224 6.9k
Li Shen China 43 4.0k 1.1× 1.4k 0.8× 1.5k 1.0× 1.1k 0.9× 937 0.9× 195 6.7k
Ping‐Kun Zhou China 38 4.6k 1.3× 1.3k 0.7× 1.4k 1.0× 865 0.7× 949 0.9× 286 7.7k
Jian Liu China 43 3.4k 0.9× 1.5k 0.8× 1.3k 0.9× 1.4k 1.1× 946 0.9× 307 6.9k
Ying Zhang China 40 3.5k 1.0× 1.2k 0.7× 1.8k 1.2× 637 0.5× 578 0.5× 258 6.2k
Haiyan Li China 40 2.7k 0.8× 1.3k 0.7× 1.2k 0.8× 948 0.7× 715 0.7× 270 5.8k
Thorsten Cramer Germany 35 3.7k 1.0× 2.8k 1.6× 1.1k 0.8× 1.8k 1.4× 651 0.6× 78 8.2k
Yu‐Sun Chang Taiwan 53 4.8k 1.3× 2.0k 1.1× 2.9k 2.0× 1.2k 0.9× 654 0.6× 247 9.0k
Gopal C. Kundu India 50 3.6k 1.0× 1.5k 0.8× 1.5k 1.1× 877 0.7× 598 0.6× 134 7.3k
Dan Li China 45 5.6k 1.6× 3.6k 2.0× 1.5k 1.0× 723 0.6× 837 0.8× 390 8.7k
Mingxing Li China 40 2.6k 0.7× 1.1k 0.6× 917 0.6× 700 0.5× 819 0.8× 192 5.4k

Countries citing papers authored by Xiaoling Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).

Fields of papers citing papers by Xiaoling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.

Co-authorship network of co-authors of Xiaoling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Li. A scholar is included among the top collaborators of Xiaoling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Li. Xiaoling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoling, Eric E. Gardner, Sonia Molina‐Pinelo, et al.. (2025). Lineage plasticity and histological transformation: tumor histology as a spectrum. Cell Research. 35(11). 803–823. 1 indexed citations
2.
3.
He, Lingfeng, Abdullah Amru Indera Luthfi, Noorashikin Md Saleh, et al.. (2025). BSFL biodiesel production and cost reduction: A review. Fuel Processing Technology. 271. 108206–108206. 3 indexed citations
4.
5.
Luo, Man, Xiaoling Li, Jing Lin, et al.. (2025). The Guanylate Cyclase Soluble Subunit Alpha-1 Deficiency Impairs Angiogenesis in Zebrafishes and Mice: In Vivo and In Vitro Studies. Molecular Neurobiology. 62(7). 8248–8260. 2 indexed citations
6.
Zhang, Huihong, Bing Yang, Xiaoqing Zhang, et al.. (2025). Retinal OCT image segmentation with deep learning: A review of advances, datasets, and evaluation metrics. Computerized Medical Imaging and Graphics. 123. 102539–102539. 3 indexed citations
7.
Li, Xiaoling, Yasmeen M. Butt, Marta Z. Pacia, et al.. (2025). Sodium glucose co-transporter 2 inhibitor empagliflozin prevents endothelial dysfunction induced by oscillatory shear stress. Biomedicine & Pharmacotherapy. 192. 118670–118670.
8.
Li, Xiaoling, et al.. (2024). Sublingual permeability of model drugs in New Zealand White Rabbits: In Vitro-In vivo correlation. International Journal of Pharmaceutics. 668. 124998–124998. 1 indexed citations
9.
Li, Xiaoling, et al.. (2024). Plasma lipidomics profiling in predicting the chemo-immunotherapy response in advanced non-small cell lung cancer. Frontiers in Oncology. 14. 1348164–1348164. 2 indexed citations
10.
Li, Xiaoling, et al.. (2024). Empagliflozin prevents TNF-α induced endothelial dysfunction under flow -the potential involvement of calcium and sodium-hydrogen exchanger. European Journal of Pharmacology. 986. 177147–177147. 7 indexed citations
11.
Liu, Xianhong, et al.. (2024). Unraveling CCL20's role by regulating Th17 cell chemotaxis in experimental autoimmune prostatitis. Journal of Cellular and Molecular Medicine. 28(10). e18445–e18445. 3 indexed citations
12.
13.
He, Shasha, et al.. (2023). Mitochondria-mediated Ferroptosis in Diseases Therapy: From Molecular Mechanisms to Implications. Aging and Disease. 15(2). 714–714. 44 indexed citations
14.
Guo, Yuanqing, Quan Liu, Xiaobin Tang, et al.. (2023). Photocatalytic membrane coated with α-Fe2O3/Fe3O4 for enhanced filtration performance and antifouling property in surface water treatment. Chemosphere. 341. 140114–140114. 4 indexed citations
15.
Li, Xiaoling, et al.. (2022). Refined-JinQi-JiangTang tablet ameliorates hypertension through activation of FGF21/FGFR1 axis in fructose-fed rats. Journal of Natural Medicines. 76(4). 765–773. 2 indexed citations
16.
Li, Xiaoling, Raphaela P. Kerindongo, Jeroen Hermanides, et al.. (2021). Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species. International Journal of Molecular Sciences. 22(11). 6044–6044. 53 indexed citations
17.
Li, Xiaoling, et al.. (2019). In Vitro Cytotoxicity and In Vivo Anti-Tumor Efficacy of CD13 Targeted Peptide-Monomethyl Auristatin E (MMAE) Conjugates. Current Trends in Biotechnology and Pharmacy. 13(2). 146–155. 3 indexed citations
18.
Wu, Ailing, Qingzhe Wu, Yujie Deng, et al.. (2018). Loss of VGLL 4 suppresses tumor PD ‐L1 expression and immune evasion. The EMBO Journal. 38(1). 36 indexed citations
19.
Zhang, Bicheng, Ming Zhou, Hou‐De Zhou, et al.. (2003). Characterization analysis of nasopharyngeal carcinoma differentially expressed gene PROL4. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 30(2). 262–265. 1 indexed citations
20.
Qiu, Xiang, et al.. (2002). Cloning of eukaryotic gene and expression. Biotechnology(Faisalabad). 12(5). 11–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Shen Breakdown of academic impact, for papers by Ping‐Kun Zhou Breakdown of academic impact, for papers by Jian Liu Breakdown of academic impact, for papers by Ying Zhang Breakdown of academic impact, for papers by Haiyan Li Breakdown of academic impact, for papers by Thorsten Cramer Breakdown of academic impact, for papers by Yu‐Sun Chang Breakdown of academic impact, for papers by Gopal C. Kundu Breakdown of academic impact, for papers by Dan Li Breakdown of academic impact, for papers by Mingxing Li
Rankless by CCL
2026